Uranium Royalty (URC) Q2 2025 earnings summary

Executive summary

• Report covers three and six months ended October 31, 2024, with focus on royalty acquisitions, uranium inventory sales, and portfolio expansion.

• Net loss of $2.6 million for the six months, compared to net income of $2.4 million in the prior year period.

• Significant investments in new royalties and uranium inventory increased total assets to $301 million as of October 31, 2024.

Financial highlights

• Revenue for the six months was $10.9 million, down from $15.3 million year-over-year.

• Gross profit for the six months was $2.9 million, compared to $4.3 million in the prior year.

• Net loss per share was $(0.02) for the six months, versus earnings per share of $0.02 last year.

• Cash and restricted cash totaled $13 million at period end, down from $21.2 million at April 30, 2024.

• Inventories increased to $221 million, reflecting higher uranium holdings.

Outlook and guidance

• Management believes current cash reserves and liquid assets provide sufficient working capital for at least the next twelve months.

• Remaining commitment to purchase 100,000 pounds U3O8 for $6.8 million due in April 2025.